Silexion Therapeutics Ltd.
Price Action
Technical Summary
WEAKENINGSilexion Therapeutics Ltd. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is moderate (RS Rating: 59), indicating performance broadly in line with the market. Earnings contraction of 227% provides fundamental context to the price action. However, price is extended 50% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.03 | +16.38% | ABOVE |
| 50 SMA | $0.02 | +49.78% | ABOVE |
| 100 SMA | $0.03 | +21.90% | ABOVE |
| 150 SMA | $0.03 | +11.33% | ABOVE |
| 200 SMA | $0.03 | +8.09% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SLXNW in an uptrend right now?
SLXNW has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is SLXNW overbought or oversold?
SLXNW's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.
Is SLXNW outperforming the market?
SLXNW has a Relative Strength (RS) Rating of 59 out of 99. SLXNW is performing about average compared to the market.
Where is SLXNW in its 52-week range?
SLXNW is trading at $0.03, which is 33% of its 52-week high ($0.10) and 26% above its 52-week low ($0.01).
How volatile is SLXNW?
SLXNW has a Beta of 4.24 and 52-week volatility of 300%. It's more volatile than the S&P 500 - expect bigger swings.